18 Dec 2019

Mitral valve replacement and repair

Improving patient access and clinical outcomes for valvular heart disease

Sponsored by Edwards Lifesciences

Chairpersons: I. Al Rashdan, M. Tuzcu

Panellists: K. Al-Shaibi, A. Alenezi, K. Almerri, M. Balghith, A. Edris, F. Sawaya, M. Traina

SHOW MORE

Summary

Consult this session on valvular heart disease to learn more about the indication expansion for aortic stenosis patients and the implication of valve design choice for the patient's future, and discover some new treatment options for mitral valve disease.

Learning Objectives

To understand indication expansion for aortic stenosis patients
To learn about the implication of valve design choice
To learn new treatment options for mitral valve disease

Presentations available when logged in:

Low risk data PATNER 3 trial
Why valve design matters to patients’ future?
Future coronary access challenges
Early discharge for TAVI patients
Indication expansion with valve-in-valve aortic
Indication expansion with valve-in-valve mitral
Improving outcomes for mitral regurgitation patients with Edwards PASCAL transcatheter valve repair system

Log in or create account for free

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…